Table 4 Levels and reducing percentage of LDL-C and duration in each group in Western and Asian (Mean ± SD)
Group | N | Mean LDL-C at baseline (mg) | Mean LDL-C at follow up (mg) | Mean reducing percentage | Actual range of reducing percentage | Duration (month) | |
|---|---|---|---|---|---|---|---|
Western | ≤70 mg | 905 | 123.2 ± 6.9 | 61.9 ± 0.9 | 49.4 ± 3.5 | 37 ~ 53 | 23.1 ± 4.3 |
>70 ≤ 100 HPmg | 812 | 131.3 ± 15.2 | 73.6 ± 4.8 | 43.2 ± 2.2 | 41.5 ~ 46.7 | 21.7 ± 3.1 | |
>70 ≤ 100 MPmg | 1548 | 91.3 ± 6.9 | 82.4 ± 8.2 | 9.0 ± 4.5 | 3.6 ~ 14.9 | 19.8 ± 2.7 | |
>70 ≤ 100 LPmg | 1061 | 88.5 ± 5.5 | 91.5 ± 5.4 | −4.7 ± 2.5 | −1.7 ~ −8.5 | 19.9 ± 4.5 | |
>100 mg | 464 | 123.4 ± 28.9 | 106.3 ± 4.4 | 8.7 ± 17.5 | −10.9 ~ 25.0 | 18.0 ± 0.0 | |
>50% | 349 | 130.4 ± 0.0 | 60.8 ± 0.0 | 53.4 ± 0.0 | 53.4 ~ 53.4 | 24.0 ± 0.0 | |
>40 ≤ 50% | 1332 | 126.9 ± 13.1 | 69.3 ± 6.5 | 45.0 ± 2.8 | 41.5 ~ 47.8 | 22.6 ± 2.7 | |
>30 ≤ 40% | 36 | 100.2 ± 30.2 | 63.1 ± 17.4 | 37.0 | 37 ~ 37 | 2.0 ± 0.0 | |
>0 ≤ 30% | 1797 | 99.4 ± 21.4 | 86.2 ± 12.2 | 11.2 ± 6.9 | 3.6 ~ 25.0 | 19.5 ± 2.6 | |
<0% | 1276 | 89.1 ± 5.3 | 93.2 ± 6.2 | −5.6 ± 3.1 | −1.7 ~ −10.9 | 19.6 ± 4.2 | |
Asian | ≤70 mg | 345 | 111.5 ± 4.3 | 57.0 ± 5.0 | 47.2 ± 1.7 | 44 ~ 49 | 6.9 ± 2.1 |
>70 ≤ 100 HPmg | 540 | 134.2 ± 7.8 | 84.0 ± 5.0 | 36.1 ± 1.8 | 32.3 ~ 39.0 | 11.0 ± 2.2 | |
>100 mg | 235 | 128.6 ± 10.5 | 117.2 ± 11.9 | 7.3 ± 10.7 | 0 ~ 32 | 7.8 ± 2.8 | |
>40 ≤ 50% | 345 | 111.5 ± 4.3 | 57.0 ± 5.0 | 47.2 ± 1.7 | 44 ~ 49 | 6.9 ± 2.1 | |
>30 ≤ 40% | 558 | 134.7 ± 8.1 | 84.6 ± 5.8 | 36.0 ± 1.9 | 32 ~ 39 | 10.9 ± 2.4 | |
>0 ≤ 30% | 217 | 126.9 ± 9.1 | 118.3 ± 11.5 | 5.3 ± 8.3 | 0 ~ 20.0 | 8.0 ± 2.8 | |